Replies to post #55888 on RespireRx Pharmaceuticals Inc (fka RSPI)

[NeutrinoKid]

Sounds alright.

[LTListener]

I suspect the 15 million would be for the OSA program (ResolutionRx) division, as it is roughly the amount yet needed there. Be interesting if they get any takers or possibly a partner?

Now what would they need 25 million for in EndeavourRx if grant funding is likely for IND enabling of epilepsy and they just started ADHD grant application, likely IND enabling as well with maybe CX1739? Hmmm..

[LTListener]

Thoughts on whether ADHD grant for CX717 or CX1739.. I know past trials done with 717, but isn’t CX1739 newer and far superior, longer patent life?